Table 6 Improvement in ECOG after the treatment of alectinib
Patients with CNS-related symptoms in the baseline, n = 28 | Number of patients |
|---|---|
No improvement in ECOG after the treatment of alectinib | 8 (28.6%) |
ECOG was improved by 1 point after the treatment of alectinib | 14 (50%) |
ECOG was improved by 2 points after the treatment of alectinib | 6 (21.4%) |